Added to YB: 2026-09-14
Pitch date: 2026-07-02
SEER [bullish]
Seer, Inc.
Author Info
No bio for this author
Company Info
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Market Cap
$107.4M
Pitch Price
N/A
Price Target
2.45
Dividend
N/A
EV/EBITDA
0.35
P/E
-1.59
EV/Sales
-1.62
Sector
Life Sciences Tools and Services
Category
special_situation
Seer, Inc. - $SEER
SEER: Seer trades at ~$1.63, roughly 65% of a conservative $2.45 per-share YE26 net-cash estimate, with no base-case value assigned to Proteograph or its NOLs. Radoff-JEC and founder Omid Farokhzad now offer separate paths to approximately $2.45 upfront plus contingent value. The principal risk is that neither transaction proceeds and the incumbent board continues funding a commercially unproven standalone plan that does not reach breakeven until 2031.
Read full article (16 min)